On September 17, Revolution Medicines, Inc. fell 5.1% in regular trading, trading at $194.58 USD/share, with Turnover of $341 million.
Within the Biotechnology sector where Revolution Medicines, Inc. belongs, individual stocks showed mixed performance. Among individual stocks, Moderna down 0.86%, AbbVie down 0.48%, Amgen down 0.02%, Gilead Sciences up 0.59%, Natera down 1.89%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)